EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of Mitochondrial DNA Methylation of Alzheimer’s Disease in Plasma Cell-Free DNA

Binrong Ding, Xuewei Zhang, Zhengqing Wan, Feng Tian, Jie Ling, Jieqiong Tan, Xiaoqing Peng

Diagnostics · 12.07.2023 · 13 (14) · 2351

DOI: 10.3390/diagnostics13142351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 12.07.2023. Verfasst von Binrong Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The Third Xiangya Hospital, Central South University, Changsha 410000, China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, Central South University Innovation-Driven Research Programme, Hunan Provincial Maternal and Child Health Care Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Noninvasive diagnosis of Alzheimer’s disease (AD) is important for patients. Significant differences in the methylation of mitochondrial DNA (mtDNA) were found in AD brain tissue. Cell-free DNA (cfDNA) is a noninvasive and economical diagnostic tool. We aimed to characterize mtDNA methylation alterations in the plasma cfDNA of 31 AD patients and 26 age- and sex-matched cognitively normal control subjects. We found that the mtDNA methylation patterns differed between AD patients and control subjects. The mtDNA was predominantly hypomethylated in the plasma cfDNA of AD patients. The hypomethylation sites or regions were mainly located in mt-rRNA, mt-tRNA, and D-Loop regions. The hypomethylation of the D-Loop region in plasma cfDNA of AD patients was consistent with that in previous studies. This study presents evidence that hypomethylation in the non-protein coding region of mtDNA may contribute to the pathogenesis of AD and potential application for the diagnosis of AD.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseasecell-free DNAmitochondrial DNA methylationnoninvasive diagnosis

Autor:innen und Institutionen

  • Department of Geriatrics, The Third Xiangya Hospital, Central South University, Changsha 410000, China.
  • Health Management Center, Xiangya Hospital, Central South University, Changsha 410000, China.
  • Hengyang Medical School, University of South China, Hengyang 421001, China.
  • The 8 Ward, The Ninth Hospital of Changsha, Changsha 410000, China.
  • Medical Functional Experiment Center, School of Basic Medicine, Central South University, Changsha 410000, China.
  • Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha 410000, China.

Förderung

  • Natural Science Foundation of Hunan Province
  • Central South University Innovation-Driven Research Programme
  • Hunan Provincial Maternal and Child Health Care Hospital

Zitieren

APA

Ding, B., Zhang, X., Wan, Z., Tian, F., Ling, J., Tan, J., & Peng, X. (2023). Characterization of Mitochondrial DNA Methylation of Alzheimer’s Disease in Plasma Cell-Free DNA. Diagnostics, 13(14), 2351. https://doi.org/10.3390/diagnostics13142351

Vancouver

Ding B, Zhang X, Wan Z, Tian F, Ling J, Tan J, et al. Characterization of Mitochondrial DNA Methylation of Alzheimer’s Disease in Plasma Cell-Free DNA. Diagnostics. 2023;13(14):2351. doi:10.3390/diagnostics13142351

BibTeX
@article{Ding2023,
  author = {Ding, Binrong and Zhang, Xuewei and Wan, Zhengqing and Tian, Feng and Ling, Jie and Tan, Jieqiong and Peng, Xiaoqing},
  title = {Characterization of Mitochondrial DNA Methylation of Alzheimer’s Disease in Plasma Cell-Free DNA},
  journal = {Diagnostics},
  year = {2023},
  volume = {13},
  number = {14},
  pages = {2351},
  doi = {10.3390/diagnostics13142351}
}
Kostenlos starten →